Objective To determine the clinicopathological features of colorectal malignancies in Sri Lankan patients aged 40 years or younger, and to compare them with those of older patients.
Introduction
Colorectal carcinoma is the third most common ma lignancy world-wide (1) . It is often regarded as a disease of the elderly with a peak incidence in the 6 ch and 7 th decades (2, 3) . Recently several studies from different countries have reported colorectal carcinoma occurring in patients below 40 years of age (4, 5, 6, 7, 8) . It has been suggested that low survival in this young age group is due to more aggressive histological grades of tumour, low suspicion of malignancy in young people and delay in diagnosis (4) . There is no documentation of the clinicopathological fea tures of colorectal malignancies in young Sri Lankan pa tients. The objective of this study was to determine the clinicopathological features of colorectal malignancies in Sri Lankan patients aged 40 years or younger and to com pare them with those of older patients.
Methods
The clinicopathological features of colorectal malig nancies in 60 patients aged 40 years or younger and 245 patients aged over 40 years were analysed retrospectively. A total of 332 cases of colorectal carcinoma were available in the records of the University Department of Pathology, Colombo, for the 15-year period commencing from 1982. Twenty-seven cases were excluded due to non-availabil ity of histology slides. All patients had been Operated at the University Surgical Unit, National Hospital, Sri Lanka. The study population is not representative of the total number of patients with colorectal carcinoma operated at the University Surgical Unit during the 15-year period. Only the cases with histopathology records were studied be cause it was necessary to review the histology slides. The clinical features were obtained from information in the re quest forms and ward records. The clinicopathological fea tures of patients aged 40 years or younger were compared with those of older patients using X 2 test to assess signifi cance between proportions. A p value <0.05 was consid ered significant.
Results
Sixty colorectal malignancies (19.67%) occurred in patients aged 40 years or younger. The mean age was 34.3 (range 18 to 40) years. Of these, 2 patients were below 20 years of age. The numbers of patients in the 21-25, 26-30, 31-35 and 36-40 year age groups were respectively 3,9,14 and 32. Their clinicopathological features are summarised in Tables 1 to 3 . There were 37 males. The mean duration from onset of symptoms to diagnosis was 4.2 (range 2 to 7) months. The percentage of patients aged 40 years or younger, who had Dukes' stage A, B, C, and D tumours were re spectively 15%, 36.7%, 40% and 8.3%. The percentage of older patients who had Dukes' stage A, B, C and D tumours were respectively 13.9%, 47.3%, 30.2% and 4.1%. In this age group, in 4.5% of patients the Dukes' staging had not been done. There was no statistically significant differ ence between young and old patients in the presenting symptoms, site of tumour and Dukes' staging of colorectal malignancies. A statistically significant proportion of tumours in young patients, were mucoid (13.3%) and sig net ring cell (5%) type (p=0.003). 3.3% of young patients with colorectal carcinoma gave a family history of similar malignancy. A history of predisposing conditions (ulcer ative colitis) was present in two (3.3%) young patients.
Discussion
19.7% of Sri Lankan patients with colorectal malig nancies were 40 years of age or younger. This is similar to figures reported from Turkey (15.1%), Ghana (17.9%) and Saudi Arabia (23%) (5, 9, 6) . In developed countries the per centage of young patients with colorectal malignancies is lower. The UK (10), Scotland (4), France (7), Sweden (11), New Zealand (6) and Japan (8) report respectively 2.5%, 3%, 3.6%, 4.5%, 5,5% and 10%. The high percentage in developing countries is probably not only due to the higher population of younger people in these countries. The 2 per 100 000 incidence of colorectal carcinoma in patients below 40 years reported in the cancer registry, Maharagama (13) is higher than the incidences of 1.4 and 1.74 in Den mark (12) and Sweden (11) in people of similar age. The slight male predominance in our study is similar to studies in USA (14) , Hong Kong (15) and Turkey (5). This con trasts with the equal sex distribution or slight female pre dominance in older patients (2, 9, 16) .
The presenting symptoms of young patients in our study were similar to those of other studies (4, 5, 15, 16, 17, 18) which have also not shown a statistically significant dif ference in the presenting symptoms of young and old pa tients (4, 11, 12) .
The proportion of patients in Duke stage C and D in our study were respectively 40% and 8.3%. In other stud ies the proportion of Duke stage C tumours range from 16.7% (16) to 62% (5), while Duke stage D tumours range from 10% (5) to 70.8% (16) . Widespread intra-abdominal and distant metastases are responsible for the poor prog nosis of young patients with colorectal carcinoma (16).
In our study mucinous and signet ring cell carcino mas accounted for 13.3% and 5% of tumours in the young. This is similar to 18.8% mucinous tumours in young pa tients reported by Umpleby and Williamson (10) and 16% reported by Heys (4) . The proportion of mucinous tumours was statistically significant when compared to older Sri Lankan patients (p=0.003). Studies in Saudi Arabia (6) and Japan (8) have reported similar results. Mucinous tumours are associated with an increased risk of local recurrence and reduction of overall survival (17, 19) .
3.3% of young patients in our study gave a family history of colorectal malignancies. This is similar to the 4.34% reported by Heys in UK (4). In Turkey a family his tory of colorectal carcinoma was present in 14% of young patients (5) . Two (3.3%) of our young patients gave a his tory of ulcerative colitis. Other studies have reported pre disposing factors to be present in proportions of young patients ranging from 4% in France (7) to 37.5% in Sweden (11) . Survival data are not available in our study, as most patients were lost to follow up.
The symptoms of rectal bleeding, blood and mucus in the stools and alteration of bowel habits should lead to a suspicion of colorectal malignancy and appropriate in vestigation even if the patient is young.
